KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Other Operating Expenses (2016 - 2025)

Teladoc Health's Other Operating Expenses history spans 11 years, with the latest figure at $493.2 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 3.01% year-over-year to $493.2 million; the TTM value through Dec 2025 reached $2.1 billion, down 27.33%, while the annual FY2025 figure was $2.1 billion, 27.33% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $493.2 million at Teladoc Health, down from $503.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $7.0 billion in Q1 2022 and bottomed at -$121.3 million in Q2 2021.
  • The 5-year median for Other Operating Expenses is $502.6 million (2023), against an average of $1.1 billion.
  • The largest annual shift saw Other Operating Expenses surged 7569.0% in 2022 before it tumbled 92.95% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $399.6 million in 2021, then surged by 961.51% to $4.2 billion in 2022, then crashed by 88.46% to $489.7 million in 2023, then grew by 3.85% to $508.5 million in 2024, then decreased by 3.01% to $493.2 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Other Operating Expenses are $493.2 million (Q4 2025), $503.7 million (Q3 2025), and $502.4 million (Q2 2025).